Listed

Gentherm Inc: Form 10-Q for the period ended Sep 30, 2014

Filed with the SEC on Nov 10, 2014 and accepted by EDGAR at Nov 10, 2014, 16:39 ET.

Share

Management's discussion and analysis

As filed, 24,294 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Statements

This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Reference is made in particular to the description of our plans and objectives for future operations, assumptions underlying such plans and objectives and other forward-looking statements included in this “Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in other places in this Report. Such statements may be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof and are based on management’s current expectations and beliefs. Such statements are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including risks and uncertainties set forth in this Report and under “Risk Factors” in our most recent Annual Report on Form 10-K for the year ended December 31, 2013 and subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2013.

General

Gentherm is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies and cable systems. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and identify future climatic comfort product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies that will enable new products, improve overall effectiveness of existing products and maximize customer satisfaction. New design applications of our existing technologies help us to create new product and market opportunities for thermal comfort solutions.

We operate as a Tier II supplier to the auto industry. Inherent in this market are costs and commitments well in advance of the receipt of orders (and resulting revenues) from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and systems. Revenues from these expenditures may not be realized for two to three years as the manufacturers tend to group new components and enhancements into annual or every two to three year vehicle model introductions. These customers in turn sell our product, as a component of an entire seat or seating system, to automotive original equipment manufacturers (“OEMs”).

On April 1, 2014, we acquired all of the stock of privately-held Global Thermoelectric Inc., now known as Gentherm Global Power Technologies (“GPT”). GPT is a global market leader and developer of thermoelectric generators. The principal applications for GPT’s products include natural gas well and pipeline protection systems and remote power generation for instrumentation, automation and telecommunication systems.

As part of the initiative to integrate the operations of historical Gentherm and W.E.T. Automotive Systems AG, now known as Gentherm GmbH (“Gentherm GmbH”), changes were made to Gentherm’s structure of internal organization. The financial information used by our chief operating decision maker to assess performance and allocate resources reflects the changes brought about through this initiative. See Note 5 to the consolidated condensed financial statements included herein for a further description of our reportable segments, including segment information about the reported product revenues and operating income of the Company for the three-month and nine-month periods ended September 30, 2014 and 2013.

We internally manufacture a large portion of our products at our production facilities. Other products we sell are manufactured by third parties. Our primary manufacturing locations are in Mexico, China and the Ukraine, all countries that have historically experienced a heightened degree of political, civil and labor uncertainty. Recent demonstrations and related violence in the Ukraine in particular highlight this risk to our manufacturing process. Although our manufacturing facility in the Ukraine is located in the far western part of the country and approximately 700 miles by road from Kiev, and approximately the same distance from the political unrest along the border of Ukraine and Russia, we cannot be certain that similar demonstrations, unrest and international tensions will not affect our facility. Furthermore, most of our products manufactured in the Ukraine are shipped across the border from the Ukraine to Hungary for further delivery to our customers. If that border crossing were to be closed for any reason, we would essentially experience a loss of the use of our Ukraine facility, which would have a material adverse effect on our business. Approximately 26% of our revenues are derived from products manufactured at our Ukraine facility.

Third Quarter 2014 Compared with Third Quarter 2013

Product Revenues. Product revenues for the three months ended September 30, 2014 (“Third Quarter 2014”) were $206,012,000 compared with product revenues of $171,182,000 for the three months ended September 30, 2013 (“Third Quarter 2013”), an increase of $34,830,000, or 20%. Higher revenue was primarily driven by continued strong shipments of climate controlled seat systems (“CCS”) and the revenue of $8,532,000 from GPT, which was acquired on April 1, 2014. CCS revenue increased by $19,024,000, or 28%, to $87,674,000, during Third Quarter 2014. This increase was partially the result of new program launches since Third Quarter 2013 and strong production volumes and sales of the vehicles equipped with CCS systems, particularly vehicles in the luxury segment of the automotive market. Additionally, certain vehicles that have been redesigned since the Third Quarter 2013 are experiencing very strong production and sales levels, including the General Motors full size SUV platform (“K2XX”) and the Jeep Grand Cherokee. Our seat heater revenue also increased by $7,169,000 or 10%, to $78,602,000. This reflected market penetration on certain vehicle programs and also the strong production volumes on General Motors’ K2XX platform. We also have significant growth in our heated steering wheel product which showed an increase of $1,087,000, or 14%, to $9,017,000. Our European based sales were higher than the prior year, even as local economies in that region begin to show signs of softening. Foreign currency translation of our Euro denominated product revenue did not have an impact on our product revenue results since the average US Dollar/Euro exchange rate for the Third Quarter 2014 was nearly the same as that for the Third Quarter 2013 at 1.3254. Our product revenues denominated in the Euro were €37,965,000 during the Third Quarter 2014 versus €35,683,000 during Third Quarter 2013. If further weakening in the Euro since Third Quarter 2014 continues, it will have a moderate unfavorable impact on our revenues during future periods.

Cost of Sales. Cost of sales increased to $144,427,000 in Third Quarter 2014 from $125,265,000 in Third Quarter 2013. This increase of $19,162,000, or 15%, was due to increased sales volume, including that of GPT, partially offset by higher gross margin percentages. A favorable change in product mix, greater coverage of fixed costs at the higher volume levels, favorable contribution from our new electronics manufacturing facility in China and foreign currency impact on production expenses in the Mexican Peso (“MXN”) and Ukrainian Hryvnia (“UAH”) increased historical gross profit percentage during Third Quarter 2014 to 29.9% compared to 26.8% during Third Quarter 2013. The favorable product mix is primarily attributable to the greater sales growth in CCS products on which we have historically had better margin performance. The new electronics manufacturing facility was launched during the second quarter of 2013. This new facility has since been in the process of increasing production volumes by producing existing component products that had formerly been produced by outside suppliers. Third Quarter 2014 is the third continuous reporting period where the savings from insourcing were larger than the additional overhead costs of the facility. We expect to capture further margin improvements as this manufacturing facility continues to increase production volumes. Our manufacturing plants are located in Ukraine, Mexico and China. As a result, our production labor costs are incurred in the local currency of each of those countries. During the Third Quarter 2014, MXN and UAH decreased in value to the USD by 2% and 54%, respectively.

Net Research and Development Expenses. Net research and development expenses were $15,278,000 during Third Quarter 2014 compared to $12,718,000 in Third Quarter 2013, an increase of $2,560,000, or 20%. This increase was primarily driven by additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. New product development includes automotive heated and cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products. Net research and development expenses also increased by $330,000 due to the acquisition of GPT.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

Acquisition Transaction Expenses. During the Third Quarter 2013, we incurred $326,000 in fees, legal and other expenses associated with the acquisition of Gentherm GmbH shares. During the Third Quarter 2014, we did not incur any such expenses.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $22,307,000 in Third Quarter 2014 from $18,319,000 in Third Quarter 2013, an increase of $3,988,000, or 22%. Over half of the increase in selling, general and administrative expenses was due to expenses from GPT, totaling $2,072,000 during Third Quarter 2014. The remaining increase in expenses is due to increased management incentive compensation costs, higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, and increasing sales and marketing efforts aimed at supporting our current product development strategy.

Income Tax Expense. During Third Quarter 2014, we recorded an income tax expense of $6,852,000, representing an effective tax rate of 28% on earnings before income tax of $24,140,000. During the Third Quarter 2013, we recorded an income tax expense of $3,600,000 representing an effective tax rate of 29% on earnings before income tax of $12,365,000. The effective tax rates for Third Quarter 2014 and Third Quarter 2013 were lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

YTD 2014 Compared with YTD 2013

Product Revenues. Product revenues for the nine months ended September 30, 2014 (“YTD 2014”) were $606,132,000 compared with product revenues of $479,792,000 for the nine months ended September 30, 2013 (“YTD 2013”), an increase of $126,340,000, or 26%. Higher revenue was primarily driven by continued strong shipments of CCS and revenue of $16,706,000 from GPT, which was acquired on April 1, 2014. CCS revenue increased by $68,163,000, or 37%, to $254,850,000, during the YTD 2014. This increase was partially the result of new program launches since YTD 2013 and strong production volumes and sales of the vehicles equipped with CCS systems, particularly vehicles in the luxury segment of the automotive market. Additionally, certain vehicles that have been redesigned since the YTD 2013 are experiencing very strong production and sales levels, including the General Motors K2XX platform and the Jeep Grand Cherokee. The increase was also attributable to improvement in sales to our Japan based customers who recovered from weaker sales during YTD 2013. Our seat heater revenue also increased by $33,736,000, or 16%, to approximately $240,704,000. This reflected market penetration on certain vehicle programs and also the strong production volumes on General Motors’ K2XX platform. We also have significant growth in our heated steering wheel product which showed an increase of $6,836,000, or 34%, to $26,699,000. Our European based sales were significantly higher than the prior year as local economies and car sales in that region have improved. Foreign currency translation of our Euro denominated product revenue for YTD 2014, which was €116,279,000 versus €106,103,000 during YTD 2013, increased our product revenues by $4,558,000 or 0.8%. The average US Dollar/Euro exchange rate for YTD 2014 was 1.3564 versus 1.3172 for YTD 2013.

Cost of Sales. Cost of sales increased to $426,765,000 in YTD 2014 from $354,672,000 in YTD 2013. This increase of $72,093,000, or 20%, was due to increased sales volume, including that of GPT, partially offset by higher gross margin percentages. A favorable change in product mix, greater coverage of fixed costs at the higher volume levels, favorable contribution from our new electronics manufacturing facility in China and foreign currency impact on production expenses in the Mexican Peso (“MXN”) and Ukraine Hryvnia (“UAH”) increased historical gross profit percentage during YTD 2014 to 29.6% compared with 26.1% during YTD 2013. The favorable product mix is primarily attributable to the greater sales growth in CCS products on which we have historically had better margin performance. We launched our new electronics manufacturing facility during the second quarter of 2013. This new facility has since been in the process of increasing production volumes by producing existing component products that had formerly been produced by outside suppliers. Third Quarter 2014 was the third continuous reporting period where the savings from insourcing were larger than the additional overhead costs of the facility. We expect to capture further margin improvements as this manufacturing facility continues to increase production volumes. Our manufacturing plants are located in Ukraine, Mexico and China. As a result, our production labor costs are incurred in the local currency of each of those countries. During YTD 2014, MXN and UAH decreased in value to the USD by 3.5% and 37.5%, respectively.

Net Research and Development Expenses. Net research and development expenses were $42,873,000 during YTD 2014 compared to $36,962,000 in YTD 2013, an increase of $5,911,000, or 16%. This increase was primarily driven by additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. New product development includes automotive heated and cool storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products. Net research and development expenses also increased by $573,000 due to the acquisition of GPT.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

Acquisition Transaction Expenses. During YTD 2014, we incurred $1,075,000 in fees and expenses associated with the acquisition of GPT which was completed on April 1, 2014. During the YTD 2013, we incurred $1,911,000 in fees, legal and other expenses associated with the acquisition of Gentherm GmbH shares.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $62,368,000 in YTD 2014 from $53,483,000 in YTD 2013, an increase of $8,885,000, or 17%. The increase in selling, general and administrative expenses in the first nine months includes the expenses of GPT totaling $4,034,000 since it was acquired on April 1, 2014. The remaining increase in expenses was due to increased management incentive compensation costs, higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, and increasing sales and marketing efforts aimed at supporting our current product development strategy.

Income Tax Expense. During YTD 2014, we recorded an income tax expense of $19,656,000 representing an effective tax rate of 28% on earnings before income tax of $69,946,000. This amount included unfavorable adjustments relating to previously unrecognized tax expenses offset partially by a shift in the mix of income by legal jurisdiction favoring lower statutory tax rate locations. Our estimated tax rate without these adjustments is 27% based upon a forecast of our full year results. During the Second Half 2013, we recorded an income tax expense of $6,343,000 representing an effective tax rate of 20% on earnings before income tax of $30,545,000. This amount included a one-time benefit resulting from the American Taxpayer Relief Act of 2012 (“the Act”) which was signed into law on January 2, 2013. The Act restored the research and development credit and certain exemption under the foreign income tax rules, retroactively to the beginning of 2012. As a result, we recognized approximately $1,300,000 in benefits associated with our 2012 tax year during YTD 2013. Had the Act been adopted during 2012, the benefit would have been recorded during that year and YTD 2013 effective tax rate would have been 25%. The effective tax rates for YTD 2014 and YTD 2013 were lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

Liquidity and Capital Resources

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Based on its current operating plan, management believes cash and cash equivalents at September 30, 2014, together with cash flows from operating activities, are sufficient to meet operating and capital expenditure needs, and to service debt, for the foreseeable future. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and materially and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could materially and adversely affect our future operations and business strategy.

On August 7, 2014 we completed a refinancing of our senior credit facilities. See Note 6 to the consolidated condensed financial statements for additional information related to our new credit facilities.

The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:

(In thousands)

September 30, 2014 December 31, 2013
Cash and cash equivalents $65,169 $54,885

We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents increased by $10,284,000 in YTD 2014. Cash provided by operating activities during YTD 2014 was $45,451,000 and was attributable to net income of $50,290,000, plus non-cash adjustments. Non-cash adjustments included depreciation and amortization of $24,565,000 stock compensation of $3,449,000 and other items. Offsetting these positive operating activities was the net increase in net operating assets and liabilities of $24,712,000, including working capital items and gains on the revaluation of derivatives of $1,264,000.

As of September 30, 2014, working capital was $177,324,000 as compared to $116,786,000 at December 31, 2013, an increase of $60,538,000, or 52%. This increase was primarily related to the working capital associated with the acquisition of GPT totaling $15,453,000, increases in accounts receivable, inventory, prepaid expenses and other assets and decreases in the current portion of long-term debt totaling $25,190,000, $4,000,000, $8,240,000 and 16,623,000, respectively. These increases to working capital were partially offset by increases in accounts payable and accrued liabilities of $8,039,000 and $4,679,000, respectively, and decreases in deferred income tax assets of $6,294,000. Accounts receivable increased primarily as a result of increases in product revenues and timing differences between when sales in 2014 were realized compared with sales realized during 2013. Gentherm had proportionally more sales in the September 2014 compared with December 2013. Working Capital was also affected by changes in currency exchange rates.

Cash used in investing activities was $58,633,000 during YTD 2014, reflecting the purchases of GPT and the remaining equity in a joint venture totaling $31,739,000 and purchases of property and equipment totaling $26,990,000. Purchases of property and equipment for the period were primarily related to expansion of production capacity, as well as replacement of existing equipment. During YTD 2014, we entered into an agreement to purchase an unoccupied industrial property in Vietnam for purposes of expanding our Asia manufacturing capacity with a new production facility. We expect to begin construction of the new facility during the fourth quarter of 2014 and begin production during 2015. The new facility is estimated to cost between $10,000,000 and $15,000,000.

Cash provided by financing activities was $24,974,000 during YTD 2014, reflecting borrowings against our new Credit Agreement (the “Credit Agreement”) entered into with a syndicate of banks led by Bank of America on August 7, 2014 of $91,592,000. In addition, we received proceeds from the exercise of common stock options of $6,282,000. These amounts were partially offset by repayment of the outstanding principle amounts on our US Term Note, US Revolving Note, Europe Term Note and W.E.T. Term Note (collectively, the “Old Credit Agreements”) totaling $76,904,000. The Old Credit Agreements were repaid and extinguished on August 7, 2014. See Note 6 “Debt” to the consolidated condensed financial statements included herein for information about borrowings against the Credit Agreement and payment and extinguishment of the Old Credit Agreement.

Market risk

As filed, 7,682 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates and short term interest rates. Market risks for changes in interest rates relate primarily to our debt obligations under our Bank of America credit facilities. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from suppliers not denominated in the functional currency of an individual location, foreign plant operations, intercompany indebtedness and include exposures to the European Euro, Canadian Dollar, Hungarian Forint, Ukrainian Hryvnia, Mexican Peso, and Korean Won. The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. We record the ineffective portion of hedging instruments, if any, to other income (expense) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

In March 2008, Gentherm GmbH entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000,000 or $12,633,000 as of September 30, 2014, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of Gentherm GmbH. Under this agreement, Gentherm GmbH received interest equal to the then nine-month Euro Interbank Offered Rate (“EURIBOR”), 0.20% at September 30, 2014, plus 1.40% and pays interest equal to the nine-month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.21 at September 30, 2014, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the nine-month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as [(1.46 – current EUR/CHF rate)/current EUR/CHF rate] x 100.

In 2011, Gentherm GmbH brought a lawsuit against UniCredit Bank AG (“UniCredit”), a past financial advisor, stemming from the recommendation to invest in the aforementioned CRS. On March 25, 2013, the Munich District Court in Munich, Germany ruled in favor of Gemtherm GmbH, asserting that UniCredit violated its duty to properly advise Gentherm GmbH with respect to the initial negative market value of the CRS and UniCredit’s inherent conflict of interest in recommending that Gentherm GmbH invest in such CRS. The Munich District Court ruled that UniCredit must (1) pay €144,000 to Gentherm GmbH and (2) bear the costs of all future obligations under the CRS, which were €7,174,000 or $9,064,000 as of September 30, 2014, plus additional accrued liabilities for past due payments under the CRS of approximately €7,075,000 or $8,939,000 as of September 30, 2014. UniCredit has appealed the decision and such appeal is pending. As a result of the pending appeal, the Company cannot be certain that any portion of the award by the Munich District Court will be realized by Gentherm GmbH. See Note 7 “Derivative Financial Instruments” to the consolidated condensed financial statements included herein for information about our future obligations under the CRS as of September 30, 2014 and 2013, respectively. The Company has entered into offsetting derivative contracts designed to limit the market risk of payments due under the CRS through the end of the CRS agreement, in 2018.

Information related to the fair values of all derivative instruments in our consolidated balance sheet as of September 30, 2014 is set forth in Note 8 to the consolidated condensed financial statements included herein.

Interest Rate Sensitivity

The table below presents principal cash flows and related average interest rates by expected maturity for each of the Company’s debt obligations. The information is presented in U.S. Dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. Dollars ($USD), European Euros (€EUR) or Canadian Dollars ($CAD), as indicated in parentheses.

September 30, 2014

Liabilities Long Term Debt: 2014 2015 2016 2017 2018 2019 Total Fair Value
Fixed Rate (€EUR) $395 $658 $— $— $— $— $1,053 $1,053
Average Interest Rate 4.20% 4.20% 4.20%
Fixed Rate (€EUR) $— $1,011 $1,011 $1,011 $1,011 $1,009 $5,053 $5,053
Average Interest Rate 4.25% 4.25% 4.25% 4.25% 4.25% 4.25%
Variable Rate ($USD) $625 $2,500 $2,812 $3,750 $4,063 $36,250 $50,000 $50,000
Average Interest Rate 1.98% 1.98% 1.98% 1.98% 1.98% 1.98% 1.98%
Variable Rate (€EUR) $316 $1,263 $1,421 $1,895 $2,053 $18,319 $25,267 $25,267
Average Interest Rate 1.81% 1.81% 1.81% 1.81% 1.81% 1.81% 1.81%
Variable Rate ($CAD) $— $— $— $— $— $13,419 $13,419 $13,419
Average Interest Rate 3.00% 3.00%

24

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

September 30, 2014

(In thousands except rate information)

Anticipated Transactions And Related Derivatives Euro functional currency Forward Exchange Agreements: (Receive HUF/Pay EUR€) Expected Maturity or Transaction Date 2014 2015 2016 2017 2018 Thereafter Total Fair Value
Total Contract Amount (€) €1,578 €1,578 €(35)
Average Contract Rate 304.17 — — — — — 304.17
(Receive CHF/Pay EUR€)
Total Contract Amount (€) €6,218 €12,336 €12,437 €12,302 €6,151 €49,444 €1,032
Average Contract Rate 1.20 1.20 1.20 1.20 1.20 — 1.20
(Receive EUR€/Pay KRW)
Total Contract Amount (€) €5,364 €5,364 €(246)
Average Contract Rate 1,398.3 — — — — — 1,398.3
$US functional currency
Forward Exchange Agreements:
(Receive MXN/Pay USD$)
Total Contract Amount ($) $7,409 $7,409 $(56)
Average Contract Rate 13.413 — — — — — 13.413

25

Controls and procedures

As filed, 1,355 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2014, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 254 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There were no material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013. You should carefully consider the risks and uncertainties described therein.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-07-01 to 2014-09-30$206.0mus-gaap:SalesRevenueGoodsNet
Revenue9 months2014-01-01 to 2014-09-30$606.1mus-gaap:SalesRevenueGoodsNet
Cost of revenue3 months2014-07-01 to 2014-09-30$144.4mus-gaap:CostOfGoodsSold
Cost of revenue9 months2014-01-01 to 2014-09-30$426.8mus-gaap:CostOfGoodsSold
Gross profit3 months2014-07-01 to 2014-09-30$61.6mus-gaap:GrossProfit
Gross profit9 months2014-01-01 to 2014-09-30$179.4mus-gaap:GrossProfit
Selling, general and administrative3 months2014-07-01 to 2014-09-30$22.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2014-01-01 to 2014-09-30$62.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-07-01 to 2014-09-30$24.0mus-gaap:OperatingIncomeLoss
Operating income9 months2014-01-01 to 2014-09-30$73.1mus-gaap:OperatingIncomeLoss
Income tax3 months2014-07-01 to 2014-09-30$6.9mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2014-01-01 to 2014-09-30$19.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-07-01 to 2014-09-30$17.3mus-gaap:NetIncomeLoss
Net income9 months2014-01-01 to 2014-09-30$50.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-07-01 to 2014-09-30$0.48us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2014-01-01 to 2014-09-30$1.40us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-07-01 to 2014-09-30$0.49us-gaap:EarningsPerShareBasic
Basic EPS9 months2014-01-01 to 2014-09-30$1.42us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-07-01 to 2014-09-3036,271,280 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2014-01-01 to 2014-09-3035,942,811 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2014-01-01 to 2014-09-30$45.5mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2014-01-01 to 2014-09-30$27.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-09-30$65.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-09-30$328.7mus-gaap:AssetsCurrent
Total assetsAt period end2014-09-30$557.7mus-gaap:Assets
Current liabilitiesAt period end2014-09-30$151.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-09-30$277.6mus-gaap:Liabilities
Long-term debtAt period end2014-09-30$90.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2014-09-30$280.1mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001564590-14-005419. Last ingested by Listed: Oct 26, 2026, 17:44 ET. Listed shows no prices and gives no investment advice.